US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist
  • 1.060
  • 0.0000.00%
Close Apr 26 16:00 ET
  • 1.090
  • +0.030+2.83%
Post 18:54 ET
123.45MMarket Cap-848P/E (TTM)

Karyopharm Therapeutics Key Stats

Karyopharm Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Feb 29, 2024

Revenue(YoY)

33.75M

+0.50%
EPS(YoY)

-0.36

+16.28%

Strong Buy

Apr 22, 2024

Karyopharm Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 36.418M--
--2024/Q1-- / 34.473M--
Feb 29, 20242023/Q433.747M / 33.616M--
Nov 2, 20232023/Q336.009M / 37.403M--
Aug 2, 20232023/Q237.579M / 35.669M--
May 4, 20232023/Q138.698M / 36.305M--
Feb 15, 20232022/Q433.580M / 33.745M--
Nov 3, 20222022/Q336.145M / 34.834M--
Aug 4, 20222022/Q239.679M / 35.965M--
May 5, 20222022/Q147.670M / 34.408M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 36.418M--
--2024/Q1-- / 34.473M--
Feb 29, 20242023/Q433.747M / 33.616M--
Nov 2, 20232023/Q336.009M / 37.403M--
Aug 2, 20232023/Q237.579M / 35.669M--
May 4, 20232023/Q138.698M / 36.305M--
Feb 15, 20232022/Q433.580M / 33.745M--
Nov 3, 20222022/Q336.145M / 34.834M--
Aug 4, 20222022/Q239.679M / 35.965M--
May 5, 20222022/Q147.670M / 34.408M--

Unlock Free Earnings Estimates

Karyopharm Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 22, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg